HYFT (MindWalk Holdings) EBITDA per Share: $-0.14 (TTM As of Jan. 2026)


HYFT MindWalk Holdings Corp HYFT
33 GF Score
Price $1.43
GF Value $0.61
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is MindWalk Holdings EBITDA per Share?

MindWalk Holdings HYFT -2.05% 33 EBITDA per Share is $-0.14 as of Jan. 2026. GuruFocus rates HYFT with a GF Score™ of 33/100 and a GF Value™ of $0.61 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 1,137 Biotechnology companies, MindWalk Holdings ranks worse than 77.92% on this metric.

MindWalk Holdings's EBITDA per Share for the three months ended in Jan. 2026 was $-0.06. Its EBITDA per Share for the trailing twelve months (TTM) ended in Jan. 2026 was $-0.14.

During the past 3 years, the average EBITDA per Share Growth Rate was -8.60% per year. During the past 5 years, the average EBITDA per Share Growth Rate was -95.50% per year. During the past 10 years, the average EBITDA per Share Growth Rate was -17.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for MindWalk Holdings's EBITDA per Share or its related term are showing as below:

HYFT' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -201   Med: 1.2   Max: 71.7
Current: -8.6

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of MindWalk Holdings was 71.70% per year. The lowest was -201.00% per year. And the median was 1.20% per year.

HYFT's 3-Year EBITDA Growth Rate is ranked worse than
77.92% of 1137 companies
in the Biotechnology industry
Industry Median: 14.9 vs HYFT: -8.60

MindWalk Holdings's EBITDA for the three months ended in Jan. 2026 was $-2.71 Mil.

During the past 3 years, the average EBITDA Growth Rate was -29.50% per year. During the past 5 years, the average EBITDA Growth Rate was -131.70% per year. During the past 10 years, the average EBITDA Growth Rate was -74.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of MindWalk Holdings was 58.00% per year. The lowest was -407.90% per year. And the median was -15.35% per year.


MindWalk Holdings  (NAS:HYFT) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


MindWalk Holdings EBITDA per Share Related Terms


MindWalk Holdings EBITDA per Share Historical Data

* Premium members only.

The historical data trend for MindWalk Holdings's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MindWalk Holdings EBITDA per Share Chart

MindWalk Holdings Annual Data
Trend Dec15 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
EBITDA per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.07 -0.48 -0.63 -0.66 -0.62

MindWalk Holdings Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
EBITDA per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.50 0.01 -0.05 -0.05 -0.06
HYFT
33GF Score
MindWalk Holdings Corp HYFT
EBITDA per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MindWalk Holdings EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

MindWalk Holdings's EBITDA per Share for the fiscal year that ended in Apr. 2025 is calculated as

EBITDA per Share(A: Apr. 2025 )
=EBITDA/Shares Outstanding (Diluted Average)
=-20.639/33.385
=-0.62

MindWalk Holdings's EBITDA per Share for the quarter that ended in Jan. 2026 is calculated as

EBITDA per Share(Q: Jan. 2026 )
=EBITDA/Shares Outstanding (Diluted Average)
=-2.709/46.516
=-0.06

EBITDA per Share for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA per Share →
What does a EBITDA per Share of $-0.14 mean?
MindWalk Holdings (HYFT) has a EBITDA per Share of $-0.14 as of Jan. 2026. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on MindWalk Holdings and its competitors. According to the industry distribution chart, MindWalk Holdings ranks #886 out of 1137 companies in the Biotechnology industry, placing it in the top 77.9%.
Is MindWalk Holdings' EBITDA per Share too high?
MindWalk Holdings' current EBITDA per Share is $-0.14. Based on the distribution chart, MindWalk Holdings ranks #886 out of 1137 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, MindWalk Holdings has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MindWalk Holdings' EBITDA per Share compare to ANVS and GANX?
According to the Biotechnology industry distribution chart, MindWalk Holdings ranks #886 out of 1137 companies for EBITDA per Share. This places MindWalk Holdings in the lower half of its industry. The industry median EBITDA per Share is 14.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA per Share for a Biotechnology company?
The median EBITDA per Share among Biotechnology companies is 14.90, based on 1,137 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA per Share significantly above this median, while those in the bottom quartile fall well below. However, EBITDA per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA per Share mean?
A high EBITDA per Share can signal that a stock is expensive relative to its fundamentals. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on MindWalk Holdings and its competitors. For the Biotechnology industry, the median EBITDA per Share is 14.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MindWalk Holdings's current EBITDA per Share is $-0.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MindWalk Holdings stock overvalued right now?
Based on GuruFocus' analysis, MindWalk Holdings (HYFT) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.61, compared to a current price of $1.43 — trading 134.4% above its estimated fair value. The current EBITDA per Share is $-0.14. MindWalk Holdings' overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA per Share calculated?
EBITDA per Share is calculated from a company's financial statements. For MindWalk Holdings (HYFT), the current EBITDA per Share is $-0.14 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MindWalk Holdings (HYFT) Overvalued in 2026?

Based on GuruFocus' analysis, MindWalk Holdings stock appears to be overvalued. The current stock price of $1.43 is trading 134.4% above its estimated GF Value™ of $0.61. GuruFocus considers MindWalk Holdings to be Significantly Overvalued.

Key valuation signals for HYFT:

  • EBITDA per Share: $-0.14
  • GF Value™: $0.61 vs. price of $1.43 (134.4% above fair value)
  • GF Score™: 33/100 with 5 warning signs

No single metric tells the full story. See the HYFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MindWalk Holdings Business Description

Other Exchanges TQB0:Germany
Address Industrious 823 Congress Avenue, Suite 300, Austin, TX, USA, 78701
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
33GF Score

Get the complete analysis for HYFT

EBITDA per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.43
Price
$0.61
GF Value